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Cardiac surgery, because of its complexity (extensive monitoring and equipment), is 
one of the most expensive surgical treatments. It is not surprising that healthcare is 
increasingly interested in cost and cost-effectiveness of this kind of treatments. For 
the majority of cardiac surgical operations, the use of cardiopulmonary bypass 
(CPB) or heart-lung machine (HLM) is a conditio sine qua non. CPB is a technique that 
uses a HLM to temporarily take over the function of the heart and lungs during 
surgery. A HLM mechanically circulates and oxygenates blood for the body while 
bypassing the heart and lungs. The HLM is maintaining perfusion to all body 
organs and tissues while the surgeon works in a bloodless surgical field. The pre-
sent thesis contributes to a better understanding of cerebral perfusion processes 
related to the use of the heart-lung machine, and shows ways to attenuate possible 
deleterious effects. 
 
In the last decade, mortality of patients operated on while using a CPB drastically 
decreased. Reduction in neurocognitive impairment, however, did not reach the 
same magnitude, with a growing body of evidence showing the negative impact of 
CPB on clinical outcome. The two major causative factors for neuropsychological 
dysfunction after cardiac surgery are global brain hypoperfusion and cerebral 
emboli generated by either surgical or perfusion-related interventions. Additionally, 
it was found that the minority of patients having cardiac procedures (15% to 20%) 
consume more than 80% of the blood products transfused during operations. To 
counteract these problems, CPB technology has evolved with advances in oxygen-
ators design, surface biocompatibility, blood-pump technology and, more recently, 
in reducing circuit size and priming volume. In an attempt to attenuate the adverse 
effects of CPB such as inflammatory reactions, transfusion requirements and ex-
treme hemodilution, recently the use of minimized cardiopulmonary bypass sys-
tems (mCPB) has gradually increased. Evident benefits of mCPB, however, do not 
come without consequences. Venous air emboli may be sucked into the venous line 
at the site of cannulation, which can result in arterial microemboli. Additionally, 
excessively low sub-atmospheric venous line pressures can cause in-pump gaseous 
microemboli in abundance as well. It is clear that every effort should be made to 
prevent air from being entrained or formed de novo in the circuit to decrease the 
total arterial embolic load. Recent literature shows that mCPB using a volume buffer 
capacity embedded into the venous line and enhanced pump servo-regulation, 
combined with anti-obstructive venous cannula design, can prevent venous line 
pressures from peaking down to excessively low levels with concomitant gaseous 
microbubble formation, while pump speed adapts to venous drainage to maintain a 
maximal level of support available at that instance. Based on the positive results of 
clinical and preclinical trials the use of mCPB as well as the use of retrograde autol-
ogous priming technique can lead to significant cost reduction in health care. 
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Because cardiac surgery is still associated with blood transfusion, our second chal-
lenge was to attenuate the negative effect of hemodilution and homologous blood 
transfusion on clinical outcome, another issue that could have both social and 
economic importance. Next to allergic reactions, transmission of infectious diseases 
and acute lung injury, there is mounting evidence that transfusion of packed red 
blood cells increases morbidity and mortality. Moreover, acute hemodilution and 
resulting low haematocrit during CPB has demonstrated to have a detrimental 
effect on cognitive function. Additionally, transfusion of red blood cells is not only 
related to poorer early and late outcome, but also makes surgery more expensive. In 
our centre, in 2014, cardiac surgical patients consumed 12% of the total amount of 
blood products that amounted to € 560.000. Additionally, a systemic review per-
formed in 6 western European countries has shown that mean costs of transfusing 2 
units of packed red blood cells were €878 providing a burden to the health care 
system. We found that both retrograde autologous priming of the cardiopulmonary 
bypass circuit and the use of mCPB significantly attenuate acute hemodilution and 
blood transfusion requirements in coronary artery bypass surgery. Obviously, our 
both attempts proved to have a significantly positive effect on both patient safety 
and cost-effectiveness. The knowledge transfer of retrograde autologous priming 
might be an interesting technique that can be shared through continuous education. 
The industry, however, should make additional effort to create safer mCPB systems. 
Therefore, using retrograde autologous priming as well as applying mCPB should 
be considered to be an integral part of a multimodal approach for conservation of 
blood transfusion. 
  
